TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21889410

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 660

Group type: COMPARATOR
Intervention: Lamotrigine
Number of subjects: 660
Study: 19183929

Group type: EXPERIMENTAL
Intervention: 1 cycle of BEP (bleomycin, etoposid, cisplatin)
Number of subjects: 382

Group type: COMPARATOR
Intervention: RPLND (retroperitoneal lymphadenectomy)
Number of subjects: 382
Study: 17284127

Group type: EXPERIMENTAL
Intervention: 15 mg/day of aripiprazole
Number of subjects: 83

Group type: COMPARATOR
Intervention: 6 mg/day of risperidone
Number of subjects: 83
Study: 15011838

Group type: EXPERIMENTAL
Intervention: Intraoperative needle decompression of the colon (n=23)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-decompression (n=27)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (decompression and non-decompression)
Number of subjects: 50
Study: 11706963

Group type: EXPERIMENTAL
Intervention: Spontaneous migraine aura patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Visually induced migraine aura patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 18
Study: 9254274

Group type: EXPERIMENTAL
Intervention: Combined laser-ultraviolet irradiation
Number of subjects: 0
Study: 8432572

Group type: EXPERIMENTAL
Intervention: Sliding hip screw
Number of subjects: 100

Group type: COMPARATOR
Intervention: McLaughlin nail‐plate
Number of subjects: 100
Study: 3497780

Group type: EXPERIMENTAL
Intervention: Sustained-release tiaprofenic acid 600 mg once daily
Number of subjects: 485

Group type: COMPARATOR
Intervention: Standard tiaprofenic acid 300 mg tablets twice daily
Number of subjects: 485

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 485
Study: 30688793

Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Center-based pulmonary rehabilitation
Number of subjects: 45
Study: 28699544

Group type: EXPERIMENTAL
Intervention: Camino Verde intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular water supply
Number of subjects: 0
Study: 26139105

Group type: EXPERIMENTAL
Intervention: Modified paleolithic diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard diet adhering to the Nordic Nutrition Recommendations
Number of subjects: 20
Study: 24135553

Group type: EXPERIMENTAL
Intervention: Open‐Monitoring meditation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Focused Attention meditation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Relaxation control
Number of subjects: 3
Study: 22009540

Group type: EXPERIMENTAL
Intervention: Iopromide (Ultravist™, Bayer Health Care)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Iodixanol (Visipaque™, Nycomed Amersham)
Number of subjects: 200
Study: 18205247

Group type: EXPERIMENTAL
Intervention: Imputation-based strategies for handling intermittent missing values and dropouts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple partial imputation
Number of subjects: 0
Study: 16510063

Group type: EXPERIMENTAL
Intervention: COX-2 selective NSAIDs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonselective NSAIDs
Number of subjects: 0
Study: 15535881

Group type: EXPERIMENTAL
Intervention: Isolated lumbar extensor training (10-week program, 2 sessions per week, 10-15 minutes each)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isolated lumbar extensor training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 11195718

Group type: EXPERIMENTAL
Intervention: Subjective frequency rating
Number of subjects: 1916

Group type: EXPERIMENTAL
Intervention: Imagery rating
Number of subjects: 1916

Group type: EXPERIMENTAL
Intervention: Interjudge reliability
Number of subjects: 1916

Group type: EXPERIMENTAL
Intervention: Correlation between subjective frequency and imagery
Number of subjects: 1916

Group type: EXPERIMENTAL
Intervention: Validity estimates
Number of subjects: 1916
Study: 9308933

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy with endoscopic dilatation/intubation (Group 1a)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Natural course of the disease with palliation (Group 1b)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Radiotherapy with endoscopic intubation (Group 2a)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Endoscopic intubation alone (Group 2b)
Number of subjects: 104
Study: 8370487

Group type: EXPERIMENTAL
Intervention: Colposuspension according to Burch
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Suburethral sling procedure
Number of subjects: 52
Study: 3548295

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: pre drug control
Number of subjects: 10
Study: 30328956

Group type: EXPERIMENTAL
Intervention: CBD 300 mg
Number of subjects: 57

Group type: COMPARATOR
Intervention: CBD 150 mg
Number of subjects: 57

Group type: COMPARATOR
Intervention: CBD 600 mg
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 28517367

Group type: EXPERIMENTAL
Intervention: MultiPoint Pacing (MPP)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Standard biventricular (Bi-V) pacing
Number of subjects: 506

Group type: EXPERIMENTAL
Intervention: Both MPP and Bi-V pacing
Number of subjects: 506
Study: 25469520

Group type: EXPERIMENTAL
Intervention: Enhanced personal contact with patients across time coupled with basic HIV education
Number of subjects: 1228

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 1228
Study: 23408048

Group type: EXPERIMENTAL
Intervention: NavX-guided slow pathway ablation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fluoroscopy-guided slow pathway ablation
Number of subjects: 42
Study: 21247247

Group type: EXPERIMENTAL
Intervention: Candesartan (up to 12 mg/day)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Amlodipine (up to 10 mg/day)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Candesartan and Amlodipine
Number of subjects: 201
Study: 19409533

Group type: EXPERIMENTAL
Intervention: Typhoid vaccination
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline (placebo) injection
Number of subjects: 16
Study: 17701889

Group type: EXPERIMENTAL
Intervention: NN414 1.5 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: NN414 4.5 mg/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: NN414 10 mg/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: NN414 (1.5, 4.5, and 10 mg/kg)
Number of subjects: 24
Study: 15023486

Group type: EXPERIMENTAL
Intervention: Empathy intervention
Number of subjects: 268

Group type: COMPARATOR
Intervention: Baby-play control
Number of subjects: 268

Group type: COMPARATOR
Intervention: Usual service control
Number of subjects: 268
Study: 11727838

Group type: EXPERIMENTAL
Intervention: Oral Methotrexate (7.5 mg/week) combined with Naproxen (1000 mg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Naproxen (1000 mg/day) alone
Number of subjects: 51
Study: 9859964

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (3 g of the 20% liquid solution) 1 hour before each dose of TMP-SMX (trimethoprim 80 mg, sulfamethoxazole 400 mg) twice daily
Number of subjects: 238

Group type: COMPARATOR
Intervention: TMP-SMX alone
Number of subjects: 238
Study: 7626569

Group type: EXPERIMENTAL
Intervention: Hydroxypropyl methylcellulose (Ocucoat)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (Healonid)
Number of subjects: 0
Study: 2681559

Group type: EXPERIMENTAL
Intervention: 4x1 g ampicillin intravenously over 3 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard therapy only
Number of subjects: 60
Study: 847691

Group type: EXPERIMENTAL
Intervention: Progestagens (Chlormadinone acetate 2 mgx2, Medroxyprogesteroneacetate 5 mgx2, Norethisterone 5 mgx2)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Curettage
Number of subjects: 100
Study: 30886326

Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg/day for 3 weeks)
Number of subjects: 16
Study: 31391698

Group type: EXPERIMENTAL
Intervention: Visudrop (coenzyme Q + vitamin E + hypermellosis) applied during surgery and postoperatively
Number of subjects: 32

Group type: COMPARATOR
Intervention: Routine FAKO + IOL implantation surgery (Control Group)
Number of subjects: 32
Study: 28960033

Group type: EXPERIMENTAL
Intervention: DA-9601 (3 times daily for 2 weeks)
Number of subjects: 434

Group type: COMPARATOR
Intervention: DA-5204 (twice daily for 2 weeks)
Number of subjects: 434
Study: 26053217

Group type: EXPERIMENTAL
Intervention: STN stimulation ON
Number of subjects: 16

Group type: COMPARATOR
Intervention: STN stimulation OFF
Number of subjects: 16
Study: 23683286

Group type: EXPERIMENTAL
Intervention: Ultrasonic technique for removing fractured rotary files
Number of subjects: 70
Study: 21552071

Group type: EXPERIMENTAL
Intervention: Strategic Memory and Reasoning Training (SMART)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Brain Health Workshop (BHW)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: SMART
Number of subjects: 28
Study: 19631319

Group type: EXPERIMENTAL
Intervention: Serum CA 19-9
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: CA 125
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: CA 19-9 and CA 125 combined
Number of subjects: 179
Study: 17370485

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Shaoze (SI 1)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Electroacupuncture (EA) at Shangyang (LI 1)
Number of subjects: 276
Study: 15286123

Group type: EXPERIMENTAL
Intervention: New clinical trial methodology for caries studies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional two‐ to three‐year caries studies
Number of subjects: 0
Study: 11789552

Group type: EXPERIMENTAL
Intervention: New treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 150
Study: 10168895

Group type: EXPERIMENTAL
Intervention: Laser photocoagulation and aspirin treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elevated serum lipid levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 7942488

Group type: EXPERIMENTAL
Intervention: Group I (early mitral closure)
Number of subjects: 20
Study: 3076995

Group type: EXPERIMENTAL
Intervention: Killed Mycobacterium leprae added to BCG vaccination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeating BCG vaccination
Number of subjects: 0

Group type: COMPARATOR
Intervention: BCG vaccination alone
Number of subjects: 0
Study: 31423955

Group type: EXPERIMENTAL
Intervention: General dysfunctional beliefs measured by the Dysfunctional Attitude Scale (DAS)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Specific illness beliefs measured by the Illness Perceptions Questionnaire‐Revised (IPQ‐R)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale (HADS)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Psychiatric disorders assessed by the Structured Clinical Interview for DSM‐IV Axis‐I Disorders (SCID‐I)
Number of subjects: 118
Study: 30919236

Group type: EXPERIMENTAL
Intervention: Neck extension
Number of subjects: 121

Group type: COMPARATOR
Intervention: Neutral position
Number of subjects: 121
Study: 27397060

Group type: EXPERIMENTAL
Intervention: Insulin plus vildagliptin 100 mg (InsV)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Insulin alone (Ins)
Number of subjects: 32
Study: 25418987

Group type: EXPERIMENTAL
Intervention: PEG-asparaginase (Oncaspar®) 1,000 IU/m²/dose administered intramuscularly at 2 or 6 weeks intervals for a total of 30 weeks
Number of subjects: 615

Group type: COMPARATOR
Intervention: Erwinase therapy
Number of subjects: 615
Study: 23403950

Group type: EXPERIMENTAL
Intervention: DES with a biodegradable polymer (n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: DES with a permanent polymer (n=50)
Number of subjects: 100
Study: 21691606

Group type: EXPERIMENTAL
Intervention: Platform-switched configuration (narrower replaceable components)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Original protocol (control group)
Number of subjects: 26
Study: 19105270

Group type: EXPERIMENTAL
Intervention: Chinese traditional medicine (oral administration)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Celecoxib and glucosamine hydrochloride (oral administration)
Number of subjects: 60
Study: 17449992

Group type: EXPERIMENTAL
Intervention: Acupuncture-like electrical stimulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (sham stimulator)
Number of subjects: 36
Study: 15472639

Group type: EXPERIMENTAL
Intervention: gated FDG PET imaging
Number of subjects: 90
Study: 11566625

Group type: EXPERIMENTAL
Intervention: Active SLE
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HGF
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: VEGF
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TGF‐beta1
Number of subjects: 60
Study: 11284464

Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 1831

Group type: EXPERIMENTAL
Intervention: Rizatriptan 5 mg
Number of subjects: 1831

Group type: COMPARATOR
Intervention: Standard care medications
Number of subjects: 1831
Study: 7870724

Group type: EXPERIMENTAL
Intervention: Radionuclide methods (infusion dynamic ureteroscintigraphy, dynamic and static scintigraphy of the kidneys, radionuclide renography)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Radionuclide methods
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Sensitive radionuclide techniques
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group (51 patients)
Number of subjects: 246
Study: 12316112

Group type: EXPERIMENTAL
Intervention: Copper T 200
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Multiload Copper 250
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Lippes Loop C
Number of subjects: 300
Study: 28795605

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gradual reduction intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Repeated exposure to sugar-free coffee (Control)
Number of subjects: 0
Study: 30423130

Group type: EXPERIMENTAL
Intervention: Low-frequency vibration device for 20 minutes per day (Group B)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional protocol (Group A)
Number of subjects: 45
Study: 27667732

Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cochlear implantation (BiCI)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unilateral cochlear implantation (UCI)
Number of subjects: 38
Study: 26463119

Group type: EXPERIMENTAL
Intervention: Patellofemoral pain (PFP)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Baseline PFP duration (>12 months)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Lower AKPS at baseline
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: No signs of radiographic knee OA
Number of subjects: 310
Study: 25058845

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI), 100/25 μg, delivered via ELLIPTA dry powder inhaler, administered once daily
Number of subjects: 257

Group type: COMPARATOR
Intervention: Tiotropium bromide (TIO), 18 μg, administered once daily
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Tiotropium bromide (TIO)
Number of subjects: 257
Study: 22750903

Group type: EXPERIMENTAL
Intervention: Spiritual Needs Inventory (SNI)
Number of subjects: 410
Study: 19923528

Group type: EXPERIMENTAL
Intervention: IV propofol infusion (2.4 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: IV midazolam (active placebo)
Number of subjects: 40
Study: 17244788

Group type: EXPERIMENTAL
Intervention: Reinforcement based on good BTM response
Number of subjects: 2382

Group type: EXPERIMENTAL
Intervention: Reinforcement based on stable BTM response
Number of subjects: 2382

Group type: EXPERIMENTAL
Intervention: Reinforcement based on poor BTM response
Number of subjects: 2382

Group type: EXPERIMENTAL
Intervention: Reinforcement (RE+)
Number of subjects: 2382

Group type: COMPARATOR
Intervention: No reinforcement (RE‐)
Number of subjects: 2382

Group type: EXPERIMENTAL
Intervention: Reinforcement
Number of subjects: 2382
Study: 15477492

Group type: EXPERIMENTAL
Intervention: Randomized study of two regimens for the last 4 months of treatment (n = 1,075)
Number of subjects: 1244

Group type: EXPERIMENTAL
Intervention: Twice-weekly rifabutin-containing regimen for HIV-infected tuberculosis (n = 169)
Number of subjects: 1244
Study: 11452678

Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg once daily)
Number of subjects: 471

Group type: COMPARATOR
Intervention: Amoxicillin clavulanate (875 mg twice daily)
Number of subjects: 471

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 471

Group type: COMPARATOR
Intervention: Amoxicillin clavulanate
Number of subjects: 471
Study: 9549518

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IV Ig) treatment (0.4 g/kg for 5 consecutive days)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: IV Ig maintenance treatment (one infusion every week for 2-4 years)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Incidental IV Ig treatment when muscle strength deteriorated
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Electrophysiological follow-up studies
Number of subjects: 7
Study: 8311557

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - transdermal oestradiol patches twice weekly for 48 weeks plus norithisterone tablets when clinically indicated
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 3279464

Group type: EXPERIMENTAL
Intervention: Individualized teaching focused on reducing perceived barriers and reinforcing benefits of BSE
Number of subjects: 121

Group type: COMPARATOR
Intervention: Routine teaching limited to usual instruction in BSE technique
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Both groups (individualized and routine teaching)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Previously non-practicing women
Number of subjects: 121
Study: 30560329

Group type: EXPERIMENTAL
Intervention: Repetitive position change after dimethicone premedication
Number of subjects: 83

Group type: COMPARATOR
Intervention: Conventional group (no position change)
Number of subjects: 83
Study: 28208713

Group type: EXPERIMENTAL
Intervention: Encapsulated fruit and vegetable juice concentrate (6 capsules daily for 8 weeks)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Encapsulated fruit and vegetable juice concentrate (in subjects with high systemic inflammation, n = 16)
Number of subjects: 56
Study: 25839713

Group type: EXPERIMENTAL
Intervention: Treadmill-based exercise intervention
Number of subjects: 70
Study: 23539080

Group type: EXPERIMENTAL
Intervention: 10-week resistance exercise program for lower limb muscles
Number of subjects: 20
Study: 21810754

Group type: COMPARATOR
Intervention: No breastfeeding (NBF)
Number of subjects: 1761

Group type: EXPERIMENTAL
Intervention: Breastfeeding (BF)
Number of subjects: 1761
Study: 19106250

Group type: EXPERIMENTAL
Intervention: 24-h fast with placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 24-h fast with acipimox (250 mg)
Number of subjects: 14
Study: 17362511

Group type: COMPARATOR
Intervention: Clomiphene Citrate Challenge Test (CCCT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Exogenous FSH Ovarian Reserve Test (EFORT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Antral Follicle Count (AFC)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Inhibin B-increment in the EFORT
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Basal Ovarian Volume (BOV)
Number of subjects: 110
Study: 14746858

Group type: EXPERIMENTAL
Intervention: rIFN-alpha2b (1 MU, subcutaneously every other day for 12 months)
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: rIFN-gamma (0.2 mg, subcutaneously every other day for 12 months)
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Iscador M (mistletoe extract)
Number of subjects: 830

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: rIFN-alpha2b
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: rIFN-gamma
Number of subjects: 830

Group type: EXPERIMENTAL
Intervention: Iscador M
Number of subjects: 830
Study: 11008916

Group type: EXPERIMENTAL
Intervention: Maternal smoking and drinking during the period from 1 month before pregnancy through breastfeeding
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Paternal smoking
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Paternal drinking 1 month before conception
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Smoking or drinking among both parents
Number of subjects: 1008
Study: 9239165

Group type: EXPERIMENTAL
Intervention: UFT + CDDP
Number of subjects: 83

Group type: COMPARATOR
Intervention: UFT
Number of subjects: 83
Study: 8444218

Group type: EXPERIMENTAL
Intervention: Iron supplementation for 2 months
Number of subjects: 81

Group type: COMPARATOR
Intervention: Iron deficiency (baseline)
Number of subjects: 81
Study: 3092711

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patches (5, 10, and 20 mg per 24 hours)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 14
Study: 29243156

Group type: EXPERIMENTAL
Intervention: Comfort eating (measured in 2008)
Number of subjects: 1445

Group type: COMPARATOR
Intervention: High-fat/sugar food consumption (measured in 2008)
Number of subjects: 1445

Group type: COMPARATOR
Intervention: Body mass index (BMI)
Number of subjects: 1445
Study: 27688685

Group type: EXPERIMENTAL
Intervention: Saddle block (SD)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Lumbar epidural block (LE)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Caudal block (CD)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 49
Study: 24780934

Group type: EXPERIMENTAL
Intervention: IVR self-monitoring adherence (≥80% completion rate)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: IVR self-monitoring adherence
Number of subjects: 91
Study: 22579604

Group type: EXPERIMENTAL
Intervention: Image-derived input functions combined with venous manual samples (IDIF+VIF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Arterial input functions (AIF)
Number of subjects: 10
Study: 20738307

Group type: EXPERIMENTAL
Intervention: VIP-reinforced-ABVD (VIP-rABVD)
Number of subjects: 88

Group type: COMPARATOR
Intervention: CHOP/21
Number of subjects: 88